UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:  000-31191

 

The Medicines Company

(Exact name of registrant as specified in its charter)

 

8 Sylvan Way

Parsippany, New Jersey 07054

(973) 290-6000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

x

 

 

 

 

 

Rule 12g-4(a)(2)

o

 

 

 

 

 

Rule 12h-3(b)(1)(i)

x

 

 

 

 

 

Rule 12h-3(b)(1)(ii)

o

 

 

 

 

 

Rule 15d-6

o

 

 

 

 

 

Rule 15d-22(b)

o

 

 

 

 

 

Approximate number of holders of record as of the certification or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, The Medicines Company has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

 

 

THE MEDICINES COMPANY

 

 

 

 

 

 

 

Date:

January 16, 2020

 

By:

/S/ STEPHEN M. RODIN

 

 

 

 

Name:

Stephen M. Rodin

 

 

 

 

Title:

Executive Vice President and General Counsel

 

 


 

Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Medicines Charts.
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Medicines Charts.